We are delighted to share our new paper just online in NatComm @NatureComms. Microbiome studies often relates diversity to health and disease. In our gut, while diversity matters, we show that functional redundancy (FR) may count more. A thread (1/9) https://t.co/xzpXbS1VTk
CNPN is partnering with HUPO to offer two travel awards to attend HUPO 2023 in Busan, Korea. The award includes complementary registration from HUPO and $500 CDN for travel expenses.
Deadline: June 14.
https://t.co/v6q0ag29Zw
I'm excited to share that we are the finalists at the Food Tech Congress 2023 startup pitch competition! To learn more click here: https://t.co/8626CTyTtV #FTC2023
I'm excited to share that we are the finalists at the Food Tech Congress 2023 startup pitch competition! To learn more click here: https://t.co/8626CTyTtV #FTC2023
I'm excited to share that we are the finalists at the Food Tech Congress 2023 startup pitch competition! To learn more click here: https://t.co/8626CTylEn #FTC2023
Interested in TMT for #proteomics and #metaproteomics but have limited budget? See the new dry TMT approach by in BiorXiv. @Xu_Zhang1 https://t.co/aU71h1gqRP
Interested in the effects of xenobiotics on microbiomes? Check out the RapidAIM 2.0 assay to study composition and functional responses of individual human gut #microbiome to #xenobiotics. @NorthOmics@li_leyuan
iMetaLab includes (1) MetaLab Desktop, facilities proteins identification and quantitation from microbiomes; (2) iMetaReport, access database search results and data set profiles; and (3) iMetaShiny, cover functional, taxonomic, and statistical analysis. https://t.co/e2Goka1gQi
Do you use sugar substitutes? Wonder if they affect your gut #microbiome? See the article by Zhongzhi Sun et al. who systematically investigated the responses of human gut microbiomes to 21 common sugar substitute sweeteners. @NorthOmics @PharmdU @
https://t.co/Esi9S7yw3E
Dr. Mayne @JaniceEMayne et al. report, with @Proteonpharma and @BiomeMed, that healthy ex-vivo human gut #microbiota composition and function are unaffected by BAFASAL®(bacteriophage cocktail targeting Salmonella). Amazing collaboration.
@uOttawaMed
https://t.co/rjyteohvAp
MedBiome with Proteon Pharmaceutical @Proteonpharma and the University of Ottawa @uOttawa report on the effect of an anti-salmonella bacteriophage on individual human gut microbiomes using the RapidAIM technology.
https://t.co/FQLdkwm4Li
MedBiome is pleased to announce that it will attend the digital China Bio Partnering Forum on Aug 25-27 2020. Looking forward to new partnerships.
MedBiome develops Precision Microbiome Therapeutics and Nutrition.
https://t.co/ebFvr1LkaE
MEET THE COMPANY ⚡️@scale_up_garage 2020
@BiomeMed seeks to develop a system to very accurately culture the human microbiome in specialized conditions to accurately represent what’s happening in our own gut.
Find out more >> https://t.co/CudhHlVTfh
RENCONTREZ L'ENTREPRISE ⚡️ @scale_up_garage 2020
@BiomeMed cherche à concevoir un système qui cultiverait avec grande précision le microbiome humain dans des conditions spécialisées afin de représenter ce qui se passe exactement dans l’intestin.
https://t.co/z8m2GhBxtT
MedBiome's founders demonstrated, using 17 berberine analogs, that subsets of compounds have distinct effects on individual #gut#microbiome. https://t.co/ImUf8nf3OQ
The study was performed using our RapidAIM live microbiome assay. https://t.co/3ljedTjTre
Did you know that #drugs can affect bacterial functions in the gut #microbiome without changing their abundances? Only looking at microbiome composition is insufficient to understand whether drugs have functional effects on the microbiome. More details:
https://t.co/iflQzQHhRb
Should drugs, natural compounds, food additives, pesticides and other compounds be tested for effects on the human gut #microbiome ? We now have the in vitro technology, called RapidAIM, to do the testing. See publication in Microbiome https://t.co/iflQzQHhRb
@BioMedCentral
What are the effects of drugs on the gut #microbiome ? See the latest paper by Dr. Leyuan Li et al. in Microbiome on RapidAIM, an exvivo high-content assay to study drug-microbiome interactions. All drugs/drug candidates should be tested.
https://t.co/iflQzQHhRb
@li_leyuan
MedBiome announces the licensing of MetaLab from @uOttawa@uOttawaMed. MetaLab(https://t.co/nbU5Pyr1n0) is a leading software for #metaproteomics. MedBiome develops Precision Microbiome Therapeutics for #IBD and other diseases. https://t.co/rOVkr3hi5k
#microbiome